| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |